Search

everythinglearnresearchcommunity

for

Search:↓

Low-cost videomicroscopes might not be reliable for examining scalp disorders compared to standard methods.

Low-cost videomicroscopes may not be reliable for diagnosing scalp disorders, smartphones could be reasonable for teledermatology, and U.S. residency programs need more teledermatology training.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Low-cost videomicroscopes are not as reliable as standard videodermatoscopes for scalp examination due to lower image quality.

Reflectance confocal microscopy reliably identifies skin cancer features like horizontal skin tissue sections.

Yellow dots and short vellus hairs are the most common signs of Alopecia Areata (AA), and trichoscopy can help diagnose AA and track treatment progress.

Trichoscopy effectively differentiates Androgenetic Alopecia from Telogen Effluvium.

Trichoscopy is a quick, accurate, and non-invasive method to diagnose and treat non-scarring hair loss.

FAPD is a possible diagnosis for hair loss in patients of color and requires multiple evaluations for accurate diagnosis.

Trichoscopy is a valuable, quick, and non-invasive tool for diagnosing tinea capitis in children.

New criteria for diagnosing frontal fibrosing alopecia include specific scalp and eyebrow hair loss as major factors and other hair loss areas and hair analysis as minor factors.

Some people's hair loss is caused by multiple factors, with the most common being a mix of AGA and CCCA.

Using dermoscopy to guide scalp biopsies is an effective way to diagnose cicatricial alopecia.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

The study concluded that key signs of Keratosis follicularis spinulosa decalvans are changes in terminal hair and vellus hair follicles, which likely start the inflammation and damage to hair follicles.

The study found that white hair in vitiligo has specific patterns and structures, which vary with the stage of the disease and may be similar to another hair condition.

Horizontal sections of scalp biopsies are good for diagnosing Central Centrifugal Cicatricial Alopecia and help customize treatment.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Lack of small, fine hair on the front hairline is a key sign of frontal fibrosing alopecia.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

The conclusion is that accurately identifying folliculosebaceous tumors requires understanding their clinical signs and microscopic features.

Scarring alopecia, a type of hair loss, is most common in females under 35, often caused by discoid lupus erythematosus and pseudopelade of Brocq. Skin punch biopsy and histopathology are key to identifying its cause.

New LPP subtype affects vellus hairs, mimics AGA, and needs biopsy for diagnosis.

A woman's hair loss was correctly diagnosed as Lichen planopilaris after initial misdiagnosis, highlighting the usefulness of trichoscopy in diagnosing hair disorders.

Histopathology is not reliable for detecting early fibrosis in traction alopecia or for showing how severe it is.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.